Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Lake Street Upgrades Surmodics to Buy, Maintains Price Target to $43

Author: Benzinga Newsdesk | March 07, 2025 05:09pm
Lake Street analyst Brooks O'Neil upgrades Surmodics (NASDAQ:SRDX) from Hold to Buy and maintains the price target from $43 to $43.

Posted In: SRDX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist